Member Info for Supermobileman

Ken Chung/peterpharma/Onetwatmany

What's wrong? Are you abusing me now? Are you stalking me now? This is unacceptable. LSE will hear about this.

Why ain't you deramping this in a rage lately rather than ramping this up. Oh I see, you fully loaded up and have added more today.

Don't worry roger65, your deramping cheerleader onetwatmany will join you shortly after his next short/top slice.

Some disgruntled posters are spinning what Tim said.

Tim never promised anything. He never used the word "promise" as far as I'm aware.

There's a difference between "A deal will be signed by the year end" and "I promise a deal will be signed by the year end".

If Tim had said "promise", then this would be assurance as likely outcome. This is more commitment than just "A deal will be signed by the year end".

What Tim said does not constitute it will guaranteed be done, but Tim has lost credibility for saying it.

Having said that, if Tim had said the word "guarantee", then this would be even more assurance a commitment will definitely be fulfilled than the word "promise". But he never did.

How many times have we all said "I will do this" and "I will do that" and "I will be there" and "I will turn up next week", to our relatives and friends only when it came to doing it, never done it. Have they broken their promises?

Ken Chung/peterpharma/Onetwatmany

Yes I did, me old China.

Roger65,

Could you tell us what promises Tim never delivered?

Ken Chung/Peterpharma/Onetwatmany

Typical post from an ignorant person. But I understand it coming from a brainless deranged deramper.

By the way, what was yesterday's closing price again? You haven't posted your figures.

As we know in the pharmaceutical world, weight loss drugs are making the headlines. Most of the leading weight loss drugs are peptide-based technology.

I have a message for Immupharma PLC.

If immupharma does a licensing deal (not buyout deal), and with abundant upfront cash in bank, they should seriously consider additionally alongside their current autoimmune disease program, going into this weight loss development if their peptide-based P140 technology allows it.

I'm sure the potential partners not only looking at what P140 can do to autoimmune diseases now but what P140 can do beyond just treating autoimmune diseases if developed further.

Just a thought.

Ken Chung/Peterpharma/Onetwatmany

Is that stupid self-righteous Onetwatmany still bleating on about closing price. Could someone explain to this dumba55 the difference between mid price and closing price. What a amateur d1ckhead.

The OFFICIAL CLOSING PRICE.

Go and learn more English.

Ken Chung/Peterpharma/Onetwatmany

The official closing price isn't calculated by the mean average of the bid and the ask price, nor the mean average of the highest and lowest prices of the day. Stupid d1ckhead.

If you don't like how the company is run, sell up and get the hell out FFS. You can then calm down and be at peace with yourself. No more bitterness looking at share price everyday. Lovely.

Roger, have you signed the NDAs and seen the patented data? Then you know nothing.

To all on this board, who is in the position to know what is going on behind the scene? Tim or Roger? Who do you believe?

Take your pick. Invest or don't invest accordingly.

Correction, proof and not prove.

Of course, libel/defamatory can be sued in this country.

You think that was the case. Tim deliberately lied about a deal will be done by the end of the year and that he done so Lanstead could sell their shares at a huge profit? Really?

For this to happen, there has to be a collusion between Lanstead and Tim. Have you got any evidence this was the case? Then why don't you call the Financial Conduct Authority or the Serious Fraud Office.

Be careful what you say without prove. In other countries, you would be sued for libel/defamatory.

In reference to my post at 13:36. It's all there in the RNS dating back 29 September 2021.

Incredible how back then some of us here were saying, "the drug don't work", "no one will partner Immupharma ", "I will never touch this share with a barge pole", etc, etc, to now what Immupharma has achieved. How time changed.

I remember Tim said in one of his interviews something like "I like to think we have another Humira here and the initial feedback from potential partners support that".

If a licensing deal, an RNS will come straight out of the blue to announce a deal has been signed. Done.

If a takeover deal, we will know about it before it is signed. An RNS will come out to announce a takeover deal is accepted by the board of directors of Immupharma with a recommendation for shareholders to accept. We shareholders, will have to vote for it.

And on about Immupharma Biotech, indeed it was formed in 2000. But under Tim's watch, in a corporate reorganisation, Immupharma France SA along with Ureka Pharma were merged into a single legal entity which was then created, formed, established, call it what you will as Immupharma Biotech SAS in 2021. The name stuck.

My previous post has been taken down. Someone doesn't like what I wrote. I wonder who.......Hmmmmm.

Anyway here it is again. In answer to Nolupus' post at 10:46.

Immupharma Biotech subsidiary was created in 2021. Immupharma PLC parent was created or formed, call it what you will, in 2000. It is this you're referring to and you know it.

Don't be petty and admit the facts.

As I said Nolupus, get your facts right before posting.

Ureka Pharma was a subsidiary of Immupharma. It had another one called Elro Pharma alongside Ureka. Tim 'disbanded' both and created a new one called Immupharma Biotech and appointed Dr. Sebastien Goudreau as CEO. I do not know other staff changes that was originally employed by the two subsidiaries as they weren't made public.

It is more than just renaming.

To roger65 and all Tim bashers. Get your facts right before posting.

Tim was appointed CEO of Immupharma in 2021. He inherited the mess Immupharma was in after the last Phase 3 trial, including the deal struck with Avion under the previous CEO leadership. In Tim's short time as CEO, he managed to turn it around by changing the Board members and staff, reduced operating costs, and created Immupharma Biotech (France) which sprung out the new highly acclaimed P140 and next generation companion diagnostic tool.

The forthcoming deal will supplement a great accomplishment in my opinion. And not least of all, it was Tim who saved Immupharma with that vital fundraise before the Phase 3 readout. Without it, Immupharma probably wouldn't be here today.